Sense Neuro Diagnostics
PrivateLast Round
Series B
Jan 19, 2026
Est. Valuation
$32M
Total Funding Raised
$5.98M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sense Neuro Diagnostics operates in Healthcare & Life Sciences and is based in West Chester, Pennsylvania. Its latest recorded funding round was a Series B round in October 2025.
Sense Neuro Diagnostics is a healthtech company that develops non-invasive, AI-enabled neurodiagnostic medical devices for the rapid detection and continuous monitoring of stroke and traumatic brain injury.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sense Neuro Diagnostics Comparables
Compare Sense Neuro Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emvision Medical Devices | 86% | |
| BrainScope | 84% | |
| Oculogica | 84% |
For institutional investors. Book with your work email.
Sense Neuro Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 19, 2026 | ||||
| Series B | Oct 3, 2025 | ||||
| VC Round | Feb 10, 2025 | ||||
| Grant | Nov 4, 2024 | ||||
| Early Funding | Mar 17, 2023 | ||||
Grant | Aug 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sense Neuro Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QCA Ventures | VC Round, Series A, Series B |
| U.S. Department of Defense | Grant |
| U.S. Department of War | Grant |
| U.S. Army Medical Research and Development Command | Grant |
| Dayton Development Coalition | VC Round, Series B |
| Medical Technology Enterprise Consortium | Grant |
| Alloy Growth Lab | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2026
$9M round with participation from bearcatventures and Alloy Growth Lab.
- Apr 1, 2025
Gary Kurdziel appointed as new Chief Executive Officer.
For institutional investors. Book with your work email.
Sense Neuro Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sense Neuro Diagnostics's valuation, stock price, and market status.
Is Sense Neuro Diagnostics a public or private company?
Sense Neuro Diagnostics is a private company.
What is the current stock price of Sense Neuro Diagnostics?
Sense Neuro Diagnostics is a private company, so its shares have no public market price. Caplight tracks Sense Neuro Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sense Neuro Diagnostics worth (valuation)?
Sense Neuro Diagnostics's valuation is estimated at $32.0M based on funding round data.
Can I buy Sense Neuro Diagnostics stock?
Sense Neuro Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sense Neuro Diagnostics's last funding round?
Sense Neuro Diagnostics's most recent funding round was Series B on January 19, 2026.
Who are the main investors in Sense Neuro Diagnostics?
Key investors in Sense Neuro Diagnostics include QCA Ventures.
Will Sense Neuro Diagnostics IPO soon?
No public IPO plans have been announced for Sense Neuro Diagnostics.
How can I track Sense Neuro Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Sense Neuro Diagnostics's shares on secondary markets.